Showing results (141-150 of 256) with videos related to
Sort By:
Pageof 26
Life Sciences|February 9, 2005
Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicityN Asna, H Lewy, I E Ashkenazi, et al.Cancer|December 1, 1990
Interleukin-2-induced lung permeability is mediated by leukotriene B4J M Klausner, G Goldman, Y Skornick, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancerO Merimsky, A Staroselsky, M Inbar, et al.Melanoma Research|April 1, 1996
Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanomaM Gutman, S Abu-Abid, M Inbar, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1978
Decreased microviscosity of membrane lipids in leukemic cells: two possible mechanismsM Petitou, F Tuy, C Rosenfeld, et al.Cancer|August 1, 1991
Are malignant melanoma patients at higher risk for a second cancer?M Gutman, A Cnaan, M Inbar, et al.Anti-Cancer Drugs|May 2, 2000
Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II studyO Merimsky, N Wigler, Y Greif, et al.Clinical Oncology|March 1, 1983
Breast carcinoma originating in cystosarcoma phyllodesJ M Klausner, S Lelcuk, B Ilia, et al.Oncology Reports|May 19, 2011
Amputation of the lower limb as palliative treatment for debilitating musculoskeletal cancerO Merimsky, Y Kollender, J Bickels, et al.Pageof 26